| pubmed-article:14714086 | pubmed:abstractText | The results of combined therapy of chronic moderate generalized periodontitis can be improved by adding richlocaine to protocols of drug therapy: the drug reduces the time of treatment, prolongs remission, decreases the number of relapses, and stabilizes pathological processes in periodontal tissues. | lld:pubmed |
